These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25200399)

  • 21. CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.
    Merle BM; Richard F; Benlian P; Puche N; Delcourt C; Souied EH
    PLoS One; 2015; 10(7):e0130816. PubMed ID: 26132079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population.
    Ricci F; Zampatti S; D'Abbruzzi F; Missiroli F; Martone C; Lepre T; Pietrangeli I; Sinibaldi C; Peconi C; Novelli G; Giardina E
    Arch Ophthalmol; 2009 Oct; 127(10):1368-72. PubMed ID: 19822855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus.
    Sardell RJ; Persad PJ; Pan SS; Whitehead P; Adams LD; Laux RA; Fortun JA; Brantley MA; Kovach JL; Schwartz SG; Agarwal A; Haines JL; Scott WK; Pericak-Vance MA
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6107-6115. PubMed ID: 27832277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
    Loane E; Nolan JM; McKay GJ; Beatty S
    Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Nikkhah H; Bonyadi M; Soheilian M
    Acta Ophthalmol; 2018 Mar; 96(2):e105-e110. PubMed ID: 28593728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association analysis of CFH and ARMS2 gene polymorphisms in a Brazilian cohort with age-related macular degeneration.
    Almeida LN; Melilo-Carolino R; Veloso CE; Pereira PA; Bastos-Rodrigues L; Sarubi H; Miranda DM; Soubrane G; De Marco L; Nehemy MB
    Ophthalmic Res; 2013; 50(2):117-22. PubMed ID: 23867343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.
    Ersoy L; Schick T; de Graft D; Felsch M; Hoyng CB; den Hollander AI; Kirchhof B; Fauser S; Liakopoulos S
    Br J Ophthalmol; 2016 Aug; 100(8):1047-51. PubMed ID: 26614632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.
    Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS;
    JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study.
    Farinha C; Barreto P; Coimbra R; Cachulo ML; Melo JB; Cunha-Vaz J; Lechanteur Y; Hoyng CB; Silva R
    Acta Ophthalmol; 2023 Mar; 101(2):185-199. PubMed ID: 36036675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
    Buentello-Volante B; Rodriguez-Ruiz G; Miranda-Duarte A; Pompa-Mera EN; Graue-Wiechers F; Bekker-Méndez C; Ayala-Ramirez R; Quezada C; Rodríguez-Loaiza JL; Zenteno JC
    Mol Vis; 2012; 18():2518-25. PubMed ID: 23112567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
    Yu JJ; Agrón E; Clemons TE; Domalpally A; van Asten F; Keenan TD; Cukras C; Chew EY;
    Ophthalmology; 2019 Feb; 126(2):261-273. PubMed ID: 30142373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Awh et al.: CFH and ARMS2 Genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration (Ophthalmology 2013;120:2317-23).
    Schwartz SG
    Ophthalmology; 2014 Aug; 121(8):e38. PubMed ID: 24793508
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population.
    Connolly E; Rhatigan M; O'Halloran AM; Muldrew KA; Chakravarthy U; Cahill M; Kenny RA; Doyle SL
    Br J Ophthalmol; 2018 Dec; 102(12):1691-1695. PubMed ID: 29453225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.
    Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ
    Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
    Seddon JM; Reynolds R; Maller J; Fagerness JA; Daly MJ; Rosner B
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2044-53. PubMed ID: 19117936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.
    Seddon JM; Francis PJ; George S; Schultz DW; Rosner B; Klein ML
    JAMA; 2007 Apr; 297(16):1793-800. PubMed ID: 17456821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
    de Jong EK; Breukink MB; Schellevis RL; Bakker B; Mohr JK; Fauser S; Keunen JE; Hoyng CB; den Hollander AI; Boon CJ
    Ophthalmology; 2015 Mar; 122(3):562-70. PubMed ID: 25439433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
    van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
    Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.